相关阅读

Array ( [0] => Array ( [relateid] => 817284 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/817284.html [wapUrl] => https://m.jnnc.com/p/817284.html [published_timestamp] => 1612852207 [published] => 1612852207 [pv] => 91 [virtual_pv] => 0 [all_pv] => 91 [title] => 世卫组织评估阿斯利康新冠疫苗对变异病毒的有效性 [has_thumb] => 0 [thumb] => ) [1] => Array ( [relateid] => 819407 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/819407.html [wapUrl] => https://m.jnnc.com/p/819407.html [published_timestamp] => 1615876922 [published] => 1615876922 [pv] => 71 [virtual_pv] => 0 [all_pv] => 71 [title] => 全球确诊病例逾1.2亿 欧洲五国叫停阿斯利康疫苗接种 [has_thumb] => 1 [thumb] => https://www.jnnc.com/a/10001/202103/97122e88dbfef2174f5955a00481e1d4.jpeg ) [2] => Array ( [relateid] => 817606 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/817606.html [wapUrl] => https://m.jnnc.com/p/817606.html [published_timestamp] => 1613693055 [published] => 1613693055 [pv] => 216 [virtual_pv] => 0 [all_pv] => 216 [title] => 到啦！中国新冠疫苗落地欧盟 [has_thumb] => 0 [thumb] => ) [3] => Array ( [relateid] => 817160 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/817160.html [wapUrl] => https://m.jnnc.com/p/817160.html [published_timestamp] => 1612685298 [published] => 1612685298 [pv] => 253 [virtual_pv] => 0 [all_pv] => 253 [title] => 法国确诊病例超331万 分配首批27.3万剂阿斯利康疫苗 [has_thumb] => 0 [thumb] => ) [4] => Array ( [relateid] => 819225 [appid] => 1 [pcUrl] => https://www.jnnc.com/p/819225.html [wapUrl] => https://m.jnnc.com/p/819225.html [published_timestamp] => 1615518495 [published] => 1615518495 [pv] => 68 [virtual_pv] => 0 [all_pv] => 68 [title] => 接种者中现血栓病例 欧洲多国暂停阿斯利康疫苗接种 [has_thumb] => 1 [thumb] => https://www.jnnc.com/a/10001/202103/edd39987e931ee37d9a88e2e021c35b0.jpeg ) )
• 世卫组织评估阿斯利康新冠疫苗对变异病毒的有效性
• 全球确诊病例逾1.2亿 欧洲五国叫停阿斯利康疫苗接种
• 到啦！中国新冠疫苗落地欧盟
• 法国确诊病例超331万 分配首批27.3万剂阿斯利康疫苗
• 接种者中现血栓病例 欧洲多国暂停阿斯利康疫苗接种